Tumor initiation and metastasis formation in many cancers have been associated with emergence of a gene expression program normally active in embryonic or organ-specific stem cells. In particular, the stem cell transcription factor Sox2 is not only expressed in a variety of tumors, but is also required for their formation. Melanoma, the most aggressive skin tumor, derives from melanocytes that during development originate from neural crest stem cells. While neural crest stem cells do not express Sox2, expression of this transcription factor has been reported in melanoma. However, the role of Sox2 in melanoma is controversial. To study the requirement of Sox2 for melanoma formation, we therefore performed CRISPR-Cas9-mediated gene inactivation in human melanoma cells. In addition, we conditionally inactivated Sox2 in a genetically engineered mouse model, in which melanoma spontaneously develops in the context of an intact stroma and immune system. Surprisingly, in both models, loss of Sox2 did neither affect melanoma initiation, nor growth, nor metastasis formation. The lack of a tumorigenic role of Sox2 in melanoma might reflect a distinct stem cell program active in neural crest stem cells and during melanoma formation.Oncogene advance online publication, 3 April 2017; doi:10.1038/onc.2017.55.

Schaefer, S., Segalada, C., Cheng, P., Bonalli, M., Parfejevs, V., Levesque, M., et al. (2017). Sox2 is dispensable for primary melanoma and metastasis formation. ONCOGENE, 36(31), 4516-4524 [10.1038/onc.2017.55].

Sox2 is dispensable for primary melanoma and metastasis formation

NICOLIS, SILVIA KIRSTEN
Penultimo
;
2017

Abstract

Tumor initiation and metastasis formation in many cancers have been associated with emergence of a gene expression program normally active in embryonic or organ-specific stem cells. In particular, the stem cell transcription factor Sox2 is not only expressed in a variety of tumors, but is also required for their formation. Melanoma, the most aggressive skin tumor, derives from melanocytes that during development originate from neural crest stem cells. While neural crest stem cells do not express Sox2, expression of this transcription factor has been reported in melanoma. However, the role of Sox2 in melanoma is controversial. To study the requirement of Sox2 for melanoma formation, we therefore performed CRISPR-Cas9-mediated gene inactivation in human melanoma cells. In addition, we conditionally inactivated Sox2 in a genetically engineered mouse model, in which melanoma spontaneously develops in the context of an intact stroma and immune system. Surprisingly, in both models, loss of Sox2 did neither affect melanoma initiation, nor growth, nor metastasis formation. The lack of a tumorigenic role of Sox2 in melanoma might reflect a distinct stem cell program active in neural crest stem cells and during melanoma formation.Oncogene advance online publication, 3 April 2017; doi:10.1038/onc.2017.55.
Articolo in rivista - Articolo scientifico
Molecular Biology; Genetics; Cancer Research
English
2017
36
31
4516
4524
reserved
Schaefer, S., Segalada, C., Cheng, P., Bonalli, M., Parfejevs, V., Levesque, M., et al. (2017). Sox2 is dispensable for primary melanoma and metastasis formation. ONCOGENE, 36(31), 4516-4524 [10.1038/onc.2017.55].
File in questo prodotto:
File Dimensione Formato  
Nicolis_5.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 5.41 MB
Formato Adobe PDF
5.41 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/152492
Citazioni
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 24
Social impact